EU News - February 22

The Flemish government has approved a framework for the participation of Flemish researchers to international research infrastructures (ESFRI). This and more info on ERC grants/EU funding in this week's…

Confo Therapeutics receives grant from VLAIO

The €1 million grant will be used to support the development of new methods for screening libraries of small molecules for the discovery of new therapeutic candidates targeting G-protein coupled receptors… cluster

Because of its importance in terms of jobs and economic activity, the sector of Tourism, Events and Culture has become a major priority for the Brussels-Capital Region. Therefore a Hospitality cluster…

Looking back at 10 years Collibra

This summer VUB spin-off Collibra celebrates its 10th anniversary. CEO Felix Van de Maele looks back at the milestones of Collibra's unlikely and incredible course. Read the full interview in Trends.

EU News - February 15

The EU TechTransfer and R&D teams join forces to kick off an intensive stimulation and support trajectory for the renowned MSCA Individual Fellowships.  Read the EU newsletter here or download it below.

FWO SBO call 2018: Important changes

CHANGES 2018 Budget: no earmarked budget foreseen for economic SBO’s with spin-off finality Evaluation: Expert recommendations and written feedback from the applicants follow 2 stage internal…

EU-GIVE project

With this EU-funded project, Enterprise Europe Network (EEN) advisers help SMEs, social enterprises, start-ups and potential entrepreneurs to get the most of the opportunities offered by the collaborative…

Project call Innoviris Bridge - Green Chemistry 2018

The 2018 call of the Innoviris program Bridge dedicated (this year) to Green Chemistry is open. The objective is to fund multi-partners leading-edge research projects focusing on novel chemical products…

Ablynx: from research adventure to scientific ingenuity

What started with a lab test in 1989 at VUB by Professor Raymond Hamers, turned out to be a revolutionary scientific discovery, which is worth billions today. Read the article in De Standaard.

PharmaFluidics targets Proteomics Market

VUB spin-off and chromatography firm PharmaFluidics is looking to make inroads into markets including proteomics and clinical research with its microchip-based liquid chromatography technology. The…